TB-500 - Peptide Intelligence Monograph

Short description

The Evidence Behind the Hype.

A physician-reviewed, evidence-based examination of TB-500 from the Founder’s Institute of Medicine & Education.

This digital monograph separates what has been demonstrated in humans, what comes from related thymosin beta-4 research, what has been observed only in preclinical studies, and what simply is not yet known.

Full product description

TB-500 is widely promoted for healing and recovery. But what does the evidence actually show?

Claims surrounding TB-500 include accelerated wound healing, tendon and ligament repair, improved muscle recovery, reduced inflammation, and enhanced athletic recovery.

The scientific picture is considerably more nuanced.

One of the most important distinctions is frequently overlooked: TB-500 is not interchangeable with full-length thymosin beta-4 (Tβ4). Human clinical research involving Tβ4 cannot automatically be treated as evidence that TB-500 produces the same effects.

Rather than beginning with a conclusion, we begin with the evidence.

Using the Founder’s Institute Peptide Evidence Standard (FIPES), claims are evaluated individually and the strength, maturity, safety knowledge, and human relevance of the supporting evidence are made transparent.

Inside the monograph

• What TB-500 is—and how it differs from thymosin beta-4

• Human clinical evidence and its important limitations

• Preclinical and mechanistic evidence

• Wound-healing and tissue-repair claims

• Musculoskeletal and recovery claims

• Safety, toxicology, and unresolved risks

• Product quality and manufacturing concerns

• FDA and regulatory context

• Claim-by-claim FIPES evidence grading

• What we know, what we do not know, and what research is still needed

Physician reviewed. Evidence graded. No protocols. No dosing instructions. No promotional claims.

This publication is intended for education and scientific evidence review. It is not medical advice and does not recommend or instruct the use of TB-500.